Corcept Therapeutics
CORT
#2417
Rank
A$9.34 B
Marketcap
$88.55
Share price
2.11%
Change (1 day)
142.51%
Change (1 year)

P/S ratio for Corcept Therapeutics (CORT)

P/S ratio as of March 2025 (TTM): 9.34

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.64. At the end of 2024 the company had a P/S ratio of 7.30.

P/S ratio history for Corcept Therapeutics from 2007 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20247.305.22%
20236.9427.57%
20225.44-12.9%
20216.25-27.27%
20208.5989.9%
20194.52-26.07%
20186.12-52.75%
201712.930.61%
20169.91-8.71%
201510.9-5.22%
201411.5-62.98%
201330.9-28.3%
201243.2
2011N/A
2010N/A-100%
2009> 10006549.54%
200887.1-60.46%
2007220

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.41-52.75%๐Ÿ‡บ๐Ÿ‡ธ USA
2.47-73.57%๐Ÿ‡บ๐Ÿ‡ธ USA
4.19-55.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
16.1 72.61%๐Ÿ‡บ๐Ÿ‡ธ USA
2.41-74.15%๐Ÿ‡บ๐Ÿ‡ธ USA
3.76-59.73%๐Ÿ‡บ๐Ÿ‡ธ USA
1.01-89.21%๐Ÿ‡บ๐Ÿ‡ธ USA
5.89-36.95%๐Ÿ‡บ๐Ÿ‡ธ USA
4.83-48.29%๐Ÿ‡บ๐Ÿ‡ธ USA